Preparation of hybrid Fe3O4 nanoparticles for biomedical applications

생의학적 응용을 위한 Fe3O4 복합 나노입자의 제조

  • Published : 2016.02.29

Abstract

Superparamagnetic $Fe_3O_4$ nanoparticles with particle size from 10 to 20 nm were synthesized by coprecipitation method. Subsequently, the $Fe_3O_4$ nanoparticles were used to fabricate $Fe_3O_4/SiO_2$ core-shell nanoparticles by sol-gel method. The $Fe_3O_4/SiO_2$ nanoparticles synthesized by sol-gel method exhibit the high uniformities of particle size and shape. We also investigated the heating characteristics of $Fe_3O_4$ and $Fe_3O_4/SiO_2$ nanoparticles for biomedical applications. The $Fe_3O_4$ nanoparticles show the faster temperature increase and the higher specific loss power(SLP) value than the $Fe_3O_4/SiO_2$ nanoparticles.

Keywords

References

  1. D. Yoo, J.-H. Lee, T.-H. Shin and J. Cheon, "Theranostic Magnetic Nanoparticles", Accounts Chem. Res., 44, 10, pp.863-874, 2011. https://doi.org/10.1021/ar200085c
  2. A. S. Teja, P.-Y. Koh, "Synthesis, properties, and applications of magnetic iron oxide nanoparticles", Prog Cryst Growth Ch, 55, pp.22-45, 2009. https://doi.org/10.1016/j.pcrysgrow.2008.08.003
  3. S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. V. Elst and R. N. Muller, "Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications", Chem. Rev., 108, 6, pp.2064-2110, 2008. https://doi.org/10.1021/cr068445e
  4. D. T. Nguyen and K.-S. Kim, "Functionalization of magnetic nanoparticles for biomedical applications", Korean J . Chem. Eng, 31, 8, pp.1289-1305, 2014. https://doi.org/10.1007/s11814-014-0156-6
  5. D. T. Nguyen, I. W. Nah and K.-S. Kim, "Preparation of Porous Nanostructures Controlled by Electrospray", Korean Chem. Eng. Res, 53, 5, pp.627-631, 2015. https://doi.org/10.9713/kcer.2015.53.5.627
  6. M. Mahmoudi, S. Sant, B. Wang, S. Laurent, T. Sen, "Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy", Adv. Drug. Deliver. Rev., 63, pp.24-46, 2011. https://doi.org/10.1016/j.addr.2010.05.006